Solutions

Online Inquiry

Global Services. (Creative Biolabs Authorized)

Bone Marrow (BM-on-Chip) Model Customization Service Powered CAR-T Development

Online Inquiry

Background Service What we can offer Workflow HighlightsFAQs Related ServicesContact

The Bone Marrow (BM-on-Chip) Model Customization Service offers a robust preclinical evaluation platform that addresses the limited physiological relevance of conventional animal models, thereby reducing the risk of late-stage translational failure in cell therapy development. This service utilizes bioengineered, organotypic microphysiological systems that accurately recapitulate human bone marrow niches. By integrating three-dimensional stromal architecture, hematopoietic and immune cell dynamics, and precisely controlled biochemical gradients within perfused microfluidic environments, customized BM-on-Chip platforms enable detailed assessment of cell therapy engraftment, persistence, efficacy, and safety.

Introduction

Bone marrow-on-chip models recreate key structural, cellular, and biochemical features of human bone marrow using microengineering approaches. Recent studies demonstrate their value in modeling hematologic cancers, immune cell dynamics, and therapeutic responses. When applied to CAR-T development, BM-on-Chip systems enable controlled, human-relevant evaluation of therapeutic performance beyond conventional 2D cultures or animal models, supporting more predictive and efficient preclinical development.

Fig.1 Schematic of a bone marrow microenvironment chip.¹

Service

Creative Biolabs offers a transformative approach to preclinical CAR-T screening by replacing static assays and divergent animal models with a bioengineered, immunocompetent "Clinical-Trial-on-Chip". Our customization service provides the structural and functional biomimicry necessary to observe real-time T cell trafficking, extravasation, and cytotoxicity within a human-relevant vascularized bone marrow milieu. By utilizing this platform, you can identify responders versus non-responders and optimize CAR designs with unprecedented predictive accuracy.

Key capabilities include:

Evaluation of CAR-T efficacy against hematologic malignancies in biomimetic BM niches.
Assessment of CAR-T expansion, exhaustion, and cytokine response.
Early identification of on-target/off-tumor risks and microenvironment-mediated resistance.

Discover How We Can Help - Request a Consultation to design a chip model that meets your specific research needs.

What We Can Offer

Our customization service integrates multiple mainstream and complementary technology platforms to support CAR-T research:

Platforms of BM-on-Chip Model Customization. (Creative Biolabs Original)

Our Workflow

Required Starting Materials: To initiate a customized project, clients typically provide target antigen specifications, specific patient-derived cells or tumor cell lines, and the CAR-T candidate protocols or viral vectors to be tested.

Workflow of BM-on-Chip Model Customization. (Creative Biolabs Original)

Final Deliverables: Clients receive a comprehensive technical report including high-resolution spatiotemporal imaging data, a validated therapeutic potency index (matrix-based functional index), and detailed molecular profiling of T cell activation and tumor burden kinetics.

Our Advantages

One-stop bone marrow modeling specifically tailored for CAR-T discovery and rigorous preclinical evaluation.
Human-centric niche assembly that replicates interactions between immune, stromal, and malignant components.
Flexible microfluidics supporting real-time perfusion, cell migration, and long-term interaction studies.
Deep functional profiling of CAR-T performance, including cytotoxicity, persistence, and exhaustion markers.

FAQs

Q1: How does the BM-on-chip compare to humanized mouse models?

A1: While humanized mice are often used, they require months of preparation and often differ from human immunity. Our chip can be assembled rapidly and allows for real-time, in situ monitoring of cellular interactions that are unattainable in vivo.

Q2: Can we use matched patient-derived samples for autologous studies?

A2: Yes. Our platform is specifically designed to accommodate patient-specific BMMCs and peripheral blood cells, highlighting its potential for personalized medicine and autologous CAR-T studies.

Q3: What type of toxicities can the model predict?

A3: The model accurately recapitulates aspects of bone marrow injury, including myeloerythroid toxicity (neutropenia and anemia) induced by chemotherapy or radiation at clinically relevant exposure levels.

Q4: Is the system suitable for evaluating "off-the-shelf" allogeneic therapies?

A4: Absolutely. Our platform can evaluate allogeneic CAR-T cells and can also be used to observe graft-versus-host effects within the bioengineered niche.

Related Services

TME Chip Customization

Creative Biolabs customizes TME-on-chip platforms integrating tumor cells, stromal components, immune populations, and biochemical gradients. These biomimetic systems enable precise evaluation of CAR-T infiltration, activation, resistance, and efficacy within complex solid tumor microenvironments.

Learn More →

Vascularized Organ-on-Chip Customization

Creative Biolabs develops vascularized organ-on-chip models with perfusable microvasculature to study CAR-T trafficking, extravasation, and tumor penetration. These dynamic systems provide translational insights into delivery efficiency, immune–tissue interactions, and in vivo, like therapeutic responses.

Learn More →

Preclinical Trial-on-Chip Multi-Organ Linkage System Customization

Creative Biolabs customizes multi-organ linkage trial-on-chip systems to simulate systemic CAR-T behavior across interconnected tissues. This platform enables integrated evaluation of efficacy, safety, biodistribution, and immune-related toxicity, accelerating predictive preclinical CAR-T development.

Learn More →

Partner with Us

Creative Biolabs provides an unparalleled bioengineering platform to bridge the gap between preclinical discovery and clinical success. Our customized BM-on-chip models empower your team to evaluate therapeutic dynamics, predict toxicity, and optimize cell therapy designs with precision. Ready to transform your discovery workflow? Contact our team for a technical consultation or to request a project-specific quote.

Reference

Sharipol, Azmeer et al. "Bone Marrow Microenvironment-On-Chip for Culture of Functional Hematopoietic Stem Cells." Frontiers in bioengineering and biotechnology vol. 10 855777. 20 Jun. 2022. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.3389/fbioe.2022.855777

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.